208 related articles for article (PubMed ID: 1562286)
1. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats.
Glauert HP; Srinivasan S; Tatum VL; Chen LC; Saxon DM; Lay LT; Borges T; Baker M; Chen LH; Robertson LW
Biochem Pharmacol; 1992 Mar; 43(6):1353-9. PubMed ID: 1562286
[TBL] [Abstract][Full Text] [Related]
2. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats.
Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP
Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245
[TBL] [Abstract][Full Text] [Related]
3. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP
Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745
[TBL] [Abstract][Full Text] [Related]
4. Hepatic oxidative stress and related defenses during treatment of mice with acetylsalicylic acid and other peroxisome proliferators.
Cai Y; Appelkvist EL; DePierre JW
J Biochem Toxicol; 1995 Apr; 10(2):87-94. PubMed ID: 7562957
[TBL] [Abstract][Full Text] [Related]
5. Increased 8-hydroxydeoxyguanosine in hepatic DNA of rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
Huang CY; Wilson MW; Lay LT; Chow CK; Robertson LW; Glauert HP
Cancer Lett; 1994 Dec; 87(2):223-8. PubMed ID: 7812944
[TBL] [Abstract][Full Text] [Related]
6. Coordinate induction of acyl-CoA binding protein, fatty acid binding protein and peroxisomal beta-oxidation by peroxisome proliferators.
Vanden Heuvel JP; Sterchele PF; Nesbit DJ; Peterson RE
Biochim Biophys Acta; 1993 Jun; 1177(2):183-90. PubMed ID: 8499488
[TBL] [Abstract][Full Text] [Related]
7. Effect of the peroxisome proliferator ciprofibrate on lipid peroxidation and 8-hydroxydeoxyguanosine formation in transgenic mice with elevated hepatic catalase activity.
Nilakantan V; Spear BT; Glauert HP
Free Radic Biol Med; 1998 Jun; 24(9):1430-6. PubMed ID: 9641260
[TBL] [Abstract][Full Text] [Related]
8. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on eicosanoid concentrations in rat liver.
Wilson MW; Leung LK; Hong JT; Glauert HP
Adv Exp Med Biol; 1997; 400A():439-45. PubMed ID: 9547588
[No Abstract] [Full Text] [Related]
9. Perfluorodecanoic acid noncompetitively inhibits the peroxisomal enzymes enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase.
Borges T; Glauert HP; Robertson LW
Toxicol Appl Pharmacol; 1993 Jan; 118(1):8-15. PubMed ID: 8430427
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferation and lipid peroxidation in rat liver.
Goel SK; Lalwani ND; Reddy JK
Cancer Res; 1986 Mar; 46(3):1324-30. PubMed ID: 3943099
[TBL] [Abstract][Full Text] [Related]
11. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.
Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610
[TBL] [Abstract][Full Text] [Related]
12. Formation of 8-oxodeoxyguanosine in liver DNA and hepatic injury by peroxisome proliferator clofibrate and perfluorodecanoic acid in rats.
Kim SC; Hong JT; Jang SJ; Kang WS; Yoo HS; Yun YP
J Toxicol Sci; 1998 May; 23(2):113-9. PubMed ID: 9644651
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.
Intrasuksri U; Rangwala SM; O'Brien M; Noonan DJ; Feller DR
Gen Pharmacol; 1998 Aug; 31(2):187-97. PubMed ID: 9688458
[TBL] [Abstract][Full Text] [Related]
14. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator.
Awasthi YC; Singh SV; Goel SK; Reddy JK
Biochem Biophys Res Commun; 1984 Sep; 123(3):1012-8. PubMed ID: 6487318
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant enzymes in ciprofibrate-induced oxidative stress.
Dhaunsi GS; Singh I; Orak JK; Singh AK
Carcinogenesis; 1994 Sep; 15(9):1923-30. PubMed ID: 7923586
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strain. Co-induction of microsomal cytochrome P-450 IVA1 and peroxisome proliferation.
Makowska JM; Anders C; Goldfarb PS; Bonner F; Gibson GG
Biochem Pharmacol; 1990 Sep; 40(5):1083-93. PubMed ID: 2390105
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary selenium on the induction of altered hepatic foci and hepatic tumors by the peroxisome proliferator ciprofibrate.
Glauert HP; Beaty MM; Clark TD; Greenwell WS; Chow CK
Nutr Cancer; 1990; 14(3-4):261-71. PubMed ID: 2084622
[TBL] [Abstract][Full Text] [Related]
18. Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate.
Nilakantan V; Spear BT; Glauert HP
Carcinogenesis; 1998 Apr; 19(4):631-7. PubMed ID: 9600348
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator perfluorodecanoic acid alters glutathione and related enzymes.
Chen LC; Tatum V; Glauert HP; Chow CK
J Biochem Mol Toxicol; 2001; 15(2):107-13. PubMed ID: 11284052
[TBL] [Abstract][Full Text] [Related]
20. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
Graham MJ; Winham MA; Old SL; Gray TJ
Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
